Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1

Bibliographic Details
Main Authors:	Estany, Susanna, Vicens-Zygmunt, Vanesa, Llatjós, Roger, Montes, Ana, Penín, Rosa, Escobar, Ignacio, Xaubet, Antoni, Santos, Salud, Manresa, Frederic, Dorca, Jordi, Molina-Molina, Maria
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123829/

Similar Items

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
by: Machahua, Carlos, et al.
Published: (2016)

Erratum to: Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices
by: Vicens-Zygmunt, Vanesa, et al.
Published: (2015)

Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices
by: Vicens-Zygmunt, Vanesa, et al.
Published: (2015)

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
by: M. Molina-Molina, et al.
Published: (2018-04-01)

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease
by: Muñoz-Esquerre, Mariana, et al.
Published: (2016)

Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
by: Alcaraz, Lindsay B., et al.
Published: (2014)

Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2
by: Gabasa, Marta, et al.
Published: (2013)

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses☆
by: Jiang, Fan, et al.
Published: (2014)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Published: (1994)

Tenascin turns on the EGFR
by: Jegalian, Karin
Published: (2001)

Tenascin Supports Lymphocyte Rolling
by: Clark, Rachael A., et al.
Published: (1997)

Induction of tenascin in healing wounds
Published: (1988)

Advances in tenascin-C biology
by: Midwood, Kim S., et al.
Published: (2011)

Tenascin-X and the pick of destiny
by: Short, Ben
Published: (2014)

Immunosuppression via Tenascin-C
by: Bellone, Matteo, et al.
Published: (2015)

Tenascin-C and integrins in cancer
by: Yoshida, Toshimichi, et al.
Published: (2015)

The evolution of tenascins and fibronectin
by: Adams, Josephine C, et al.
Published: (2015)

Transcriptional regulation of tenascin genes
by: Chiovaro, Francesca, et al.
Published: (2015)

Correction: High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study
by: López-Sánchez, Marta, et al.
Published: (2014)

High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study
by: López-Sánchez, Marta, et al.
Published: (2013)

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
by: Elisabet Aliagas, et al.
Published: (2018-05-01)

Transcriptional regulation of tenascin‐W by TGF‐beta signaling in the bone metastatic niche of breast cancer cells
by: Chiovaro, Francesca, et al.
Published: (2015)

The Adhesion Modulating Properties of Tenascin-W
by: Brellier, Florence, et al.
Published: (2011)

Tenascin-C Suppresses Rho Activation
by: Wenk, Melissa B., et al.
Published: (2000)

The Adhesion Modulating Properties of Tenascin-W
by: Florence Brellier, Enrico Martina, Matthias Chiquet, Jacqueline Ferralli, Michael van der Heyden, Gertraud Orend, Johannes C. Schittny, Ruth Chiquet-Ehrismann, Richard P. Tucker
Published: (2012-01-01)

Tenascin-X: beyond the architectural function
by: Valcourt, Ulrich, et al.
Published: (2015)

Tenascin-C: Form versus function
by: Giblin, Sean P, et al.
Published: (2014)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
by: Brellier, Florence, et al.
Published: (2012)

Expression and degeneration of tenascin-C in human lung cancers.
by: Kusagawa, H., et al.
Published: (1998)

Specific expression of tenascin in human colonic neoplasms.
by: Sakai, T., et al.
Published: (1993)

Raised circulating tenascin-C in rheumatoid arthritis
by: Page, Theresa H, et al.
Published: (2012)

Tenascin-C drives persistence of organ fibrosis
by: Bhattacharyya, Swati, et al.
Published: (2016)

Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective?
by: Suzuki, Hidenori, et al.
Published: (2016)

Tenascin-C: Exploitation and collateral damage in cancer management
by: Spenlé, Caroline, et al.
Published: (2015)

TENASCIN AND FIBRONECTIN IN PLEOMORPHIC ADENOMA OF THE SALIVARY GLAND
by: Bento, Patrícia Meira, et al.
Published: (2006)

Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system
by: Imanaka-Yoshida, Kyoko, et al.
Published: (2014)

Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics
by: Pscherer, Stefan, et al.
Published: (2013)

MXRA5 is a TGF‐β1‐regulated human protein with anti‐inflammatory and anti‐fibrotic properties
by: Poveda, Jonay, et al.
Published: (2016)

Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes
by: Dubash, Adi D., et al.
Published: (2016)

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy
by: Thomes, Paul G., et al.
Published: (2016)